C atheter ablation for nonpharmacological management of pediatric patients with tachyarrhythmias has evolved during the past approximately 10 years. Direct-current energy ablation was initially used in some patients with drug-refractory, life-threatening tachyarrhythmias such as junctional ectopic-focus tachycardia and also for some children with left ventricular dysfunction due to incessant tachycardias (eg, the permanent form ofjunctional reciprocating supraventricular tachycardia and atrial ectopic-focus tachycardia.12 The extensive lesions and less-than-ideal results from direct-current energy prompted research and development of alternative energy sources that led quickly to clinical application of radiofrequency energy ablation of tachyarrhythmias in adults in the late 1980s. This apparently safer and more successful technique revolutionized the treatment of not only adults but also children and adolescents with supraventricular tachycardia in the 1990s.3-11 The 1992 report of ventricular tachycardia and sudden death during late follow-up of pediatric patients who had undergone direct-current ablation emphasizes the dangers of the direct-current ablation method but also serves as a warning against premature acceptance of any ablation technique because adverse effects may be detected only during late follow-up.12 See p 492
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In the 19 infant lambs of the second experiment, radiofrequency current was applied in a manner similar to that used clinically in patients (to the endocardial surface through a transvenous catheter with a 4-mm tip electrode). Multiple applications of radiofrequency current were given with the non-thermistor/thermocoupled catheter-tip electrode positioned on the endocardial surface of the atrium, ventricle, and along the atrioventricular annulus. Three groups of lambs were euthanized acutely, after 1 month, and after 8.5 months. Interesting findings are related both to lesion size and to histology.
Although Saul and his coauthors write that the atrial lesions (width only) and ventricular lesions (both width and depth) "clearly increased simultaneously with cardiac and whole body growth," it was not truly possible for the investigators to know if the actual lesions produced were in fact increasing in size. Therefore, it is more accurate to conclude that the mean lesion size was statistically different at the two follow-up intervals, and from this it is reasonable to conclude that the lesions appeared to have increased during animal growth.
Other limitations in methodology call for caution in interpretation of these data. While it is admirable that the investigators monitored the number of radiofrequency applications, only 65% (52% on the atrioventricular [AV] groove, 66% in the atrium, and 79% in the ventricle) were identified at postmortem examination. As is supported by the statistically fewer identifiable lesions on the AV groove, it appears that it was more difficult to maintain catheter position (and therefore electrode contact) on the AV groove. Therefore, bias may have existed toward concluding that the mean values for AV groove lesion size were not larger among the three groups. A better record of successful application and lesion production may have been achieved by using a thermistor or thermocoupled ablation catheter.
For these methodological reasons and because it is difficult to quantify histological data, caution is needed also when making conclusions based on the histological findings. Nevertheless, Saul and associates have delineated apparent differences between immature animals and those reported for adult animals showing more invasiveness (especially in the ventricle) in the immature myocardium. Their discussion and explanations for the differences are excellent and plausible, based on previously reported histological studies and radiofrequency energy, physical dynamics studies.
Although the limitations of this animal study are essential considerations, Saul and his coinvestigators have provided pediatric cardiologists with important data that directly impact the management of infants and small children with tachyarrhythmias. The authors state: ". . . the recommendation to attempt to avoid intervention in the youngest patients should probably be followed until technical improvements allow for real-time assessment of lesion size during the ablation procedure." This seems to understate the implications of the study. Even without the lamb data, the case can be made for avoiding radiofrequency catheter ablation in virtually all infants. This is based on the natural history data (also cited by the authors in their discussion), the premise that virtually all supraventricular tachycardias can be controlled with antiarrhythmic drugs, the Registry-demonstrated increased complication risk in children who weigh less than 15 kg, and these lamb data that provide concern for potential future adverse effects related to the extensive and possible growth-related expanding myocardial lesions.
If indeed there are some infants and small children who are candidates for radiofrequency catheter ablation, the data from this lamb study by Saul et Until agreement is reached on operating definitions and more data put speculation to rest, the sobering animal and clinical studies should be considered before performing radiofrequency catheter ablation in infants and small children. Rare situations may warrant recommending the procedure. Infants and small children with congenital heart disease who need intracardiac surgery but who also have an accessory AV pathway may be candidates for preoperative catheter ablation because the risk of additional surgery at the time of operation may be greater than the risk of the catheter ablation. Aside from such unusual extenuating circumstances, the current information does not appear to warrant radiofrequency ablation in infants with drug-refractory supraventricular tachycardia at this time.
